Pitfalls and success of experimental design in the development of a mixed MEKC method for the analysis of budesonide and its impurities

A mixed MEKC method for the analysis of budesonide and its related substances is presented. The micelles were formed from sodium cholate (CHOL) and 3‐(N,N‐dimethylmyristylammonio)propanesulfonate (MAPS). A multivariate optimisation was carried out with the aim of obtaining a baseline separation of all compounds. The influence of voltage, borate concentration, cholate concentration, MAPS concentration and pH was evaluated on the responses, corresponding to critical resolution values. Problems with the investigated experimental design were encountered due to the complexity of the separation process. As a consequence, a first design was not sufficient to reach the optimal conditions, but was needed in order to obtain the necessary information to successfully plan a second in‐depth study by means of response surface methodology. The optimal conditions were as follows: capillary total and effective lengths of 48.5 and 40.0 cm, respectively, with 50 μm id; 70 mM borate buffer (pH 8.8) containing 65 mM CHOL and 10 mM MAPS; temperature 20°C and voltage 16 kV. Separation of all the compounds, including R‐ and S‐epimers of budesonide, was obtained in a reasonable time. Validation of the method was performed for both drug substances and drug product.

[1]  Bruce N. Tattam,et al.  Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[2]  M. Khaledi,et al.  Mixed micellar electrokinetic chromatography of corticosteroids , 1994, Electrophoresis.

[3]  M. Matsuo,et al.  Separation of corticosteroids and aromatic hydrocarbons by cyclodextrin modified micellar electrokinetic chromatography , 1991 .

[4]  K. Otsuka,et al.  Micelles as pseudo-stationary phases in micellar electrokinetic chromatography. , 1997, Journal of chromatography. A.

[5]  H. Chrystyn,et al.  High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler. , 2006, Journal of pharmaceutical and biomedical analysis.

[6]  J. Paulson,et al.  Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometry. , 1992, Biological mass spectrometry.

[7]  V. G. Berezkin,et al.  The essence of chromatography , 2002 .

[8]  Bieke Dejaegher,et al.  Ruggedness and robustness testing. , 2007, Journal of chromatography. A.

[9]  K Kronkvist,et al.  Automated sample preparation for the determination of budesonide in plasma samples by liquid chromatography and tandem mass spectrometry. , 1998, Journal of chromatography. A.

[10]  R. Gotti,et al.  Microemulsion electrokinetic chromatography of corticosteroids. Effect of surfactants and cyclodextrins on the separation selectivity. , 2005, Journal of chromatography. A.

[11]  I. Mikšík,et al.  Microemulsion and micellar electrokinetic chromatography of steroids. , 1996, Journal of chromatography. B, Biomedical applications.

[12]  Y. Ishihama,et al.  Effect of urea addition in micellar electrokinetic chromatography , 1991 .

[13]  Roger Phan-Tan-Luu,et al.  Pharmaceutical Experimental Design , 1998 .

[14]  S Furlanetto,et al.  How experimental design can improve the validation process. Studies in pharmaceutical analysis , 2003, Analytical and bioanalytical chemistry.

[15]  K. Brown,et al.  Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. , 1996, Journal of chromatography. B, Biomedical applications.

[16]  M. Luyckx,et al.  High-performance liquid chromatographic method for the determination of budesonide in bronchoalveolar lavage of asthmatic patients. , 1995, Journal of chromatography. B, Biomedical applications.

[17]  L. Nilsson,et al.  High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard. , 1980, Journal of pharmaceutical sciences.

[18]  H. Haario,et al.  Optimized separation of seven corticosteroids by micellar electrokinetic chromatography , 1994, Electrophoresis.

[19]  J. Böhler,et al.  Evaluation and optimisation of separation buffers for the determination of corticosteroids with micellar electrokinetic capillary chromatography (MECC). , 1998, Journal of pharmaceutical and biomedical analysis.

[20]  Shou‐Mei Wu,et al.  Micellar electrokinetic chromatography for simultaneous determination of six corticosteroids in commercial pharmaceuticals. , 2005, Journal of separation science.

[21]  Cheng-Huang Lin,et al.  Comparison of the use of anionic and cationic surfactants for the separation of steroids based on MEKC and sweeping‐MEKC modes , 2006, Electrophoresis.

[22]  M. Khaledi,et al.  Mixed micelles of short chain alkyl surfactants and bile salts in electrokinetic chromatography: enhanced separation of corticosteroids. , 1996, Journal of chromatography. A.

[23]  L. Kartsova,et al.  Determination of steroids in biological samples by micellar electrokinetic chromatography , 2007 .

[24]  R. Gotti,et al.  Development of a CZE method for the determination of mizolastine and its impurities in pharmaceutical preparations using response surface methodology , 2007, Electrophoresis.

[25]  A. Venturini,et al.  Estimation and characterisation of budesonide tablets impurities. , 2008, Journal of pharmaceutical and biomedical analysis.

[26]  Helen Trenerry,et al.  Martindale: The complete drug reference. 37th ed. , 2011 .

[27]  H. Haario,et al.  Optimization of selectivity and resolution in micellar electrokinetic capillary chromatography with a mixed micellar system of sodium dodecyl sulfate and sodium cholate , 1996, Electrophoresis.

[28]  B. van der Burg,et al.  A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum , 2003, Clinical endocrinology.

[29]  S. Terabe,et al.  Separation and determination of lipophilic corticosteroids and benzothiazepin analogues by micellar electrokinetic chromatography using bile salts. , 1990, Journal of chromatography.

[30]  M. Khaledi,et al.  Quantitative structure-activity relationships studies with micellar electrokinetic chromatography. Influence of surfactant type and mixed micelles on estimation of hydrophobicity and bioavailability. , 1996, Journal of chromatography. A.

[31]  U. Lövgren,et al.  Determination of drugs in biosamples at picomolar concentrations using competitive ELISA with electrochemical detection: application to steroids. , 1993, Journal of pharmaceutical and biomedical analysis.

[32]  Johanna Smeyers-Verbeke,et al.  Handbook of Chemometrics and Qualimetrics: Part A , 1997 .

[33]  M. Riekkola,et al.  Mixed Micelles of Sodium Dodecyl Sulfate and Sodium Cholate: Micellar Electrokinetic Capillary Chromatography and Nuclear Magnetic Resonance Spectroscopy , 1997 .

[34]  M. Riekkola,et al.  Determination of serum corticosteroids by mixed micellar electrokinetic capillary chromatography with sodium dodecyl sulfate and sodium cholate , 1997, Electrophoresis.

[35]  G. Aherne,et al.  A sensitive radioimmunoassay for budesonide in plasma. , 1982, Journal of steroid biochemistry.